Welcome to Multibagg AI
Log in to access personalized features
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
3
Neutral
4
Bullish
7
Bearish
24
Neutral
4
Bullish
18
Bearish
21
Neutral
0
Bullish
11
Discovery themes featuring this stockDiscover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY26
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q3 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q2 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Investor Presentation
Q1 FY25
Available on Pro Plan
Unlock reports, presentations, and AI-powered insights.
Dhanuka Agritech is a pan‑India agrochemical company manufacturing and marketing herbicides, insecticides, fungicides and plant growth regulators through four manufacturing units, a recently commissioned Dahej synthesis plant, 41 warehouses, ~6,500 distributors and ~80,000 retailers, targeting over 10 million farmers with both B2C and B2B offerings across major crops and geographies.
Q3 FY26 showed a revenue decline to Rs. 409.9 crore (Q3 FY25: Rs. 445.3 crore) and PAT fell to Rs. 40.0 crore, driven by weak agrochemical demand, extended rainfall, lower commodity realisations and regulatory disruption in biostimulants; management keeps FY26 revenue guidance flat while expecting EBITDA to compress ~100bps versus prior year.
Strategically significant developments include commercialisation of a second product from Dahej in Q3 FY26, a plan to make Dahej EBITDA positive in FY27, and an MPP‑2 capex plan (~Rs. 60–70 crore) to raise technical manufacturing scale; these moves materially reduce sourcing dependence and support margin expansion over a multi‑year horizon.
Dhanuka has acquired international rights to Iprovalicarb and Triadimenol from Bayer AG; current net economic benefit (NEB) from Bayer products (Rs. ~19.5 crore in 9M) will phase out as registrations transfer, shifting future revenue recognition and improving long‑term manufacturing economics once local production ramps.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
4,841 Cr
Low Risk
16.3
20.9
1.5
3.5
1,960.00
889.95
Sales CAGR
Profit CAGR
ROE
ROCE
Discovery themes featuring this stock
Dhanuka Agritech Ltd (DHANUKA) is currently trading at 1,088.05 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Dhanuka Agritech is a pan‑India agrochemical company manufacturing and marketing herbicides, insecticides, fungicides and plant growth regulators through four manufacturing units, a recently commissioned Dahej synthesis plant, 41 warehouses, ~6,500 distributors and ~80,000 retailers, targeting over 10 million farmers with both B2C and B2B offerings across major crops and geographies. Q3 FY26 showed a revenue decline to Rs. 409.9 crore (Q3 FY25: Rs. 445.3 crore) and PAT fell to Rs. 40.0 crore, driven by weak agrochemical demand, extended rainfall, lower commodity realisations and regulatory disruption in biostimulants; management keeps FY26 revenue guidance flat while expecting EBITDA to compress ~100bps versus prior year. Strategically significant developments include commercialisation of a second product from Dahej in Q3 FY26, a plan to make Dahej EBITDA positive in FY27, and an MPP‑2 capex plan (~Rs. 60–70 crore) to raise technical manufacturing scale; these moves materially reduce sourcing dependence and support margin expansion over a multi‑year horizon. Dhanuka has acquired international rights to Iprovalicarb and Triadimenol from Bayer AG; current net economic benefit (NEB) from Bayer products (Rs. ~19.5 crore in 9M) will phase out as registrations transfer, shifting future revenue recognition and improving long‑term manufacturing economics once local production ramps.
Over the past 52 weeks, Dhanuka Agritech Ltd has traded between a low of ₹889.95 and a high of ₹1,960.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Dhanuka Agritech Ltd has a market capitalization of approximately 4,841.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Dhanuka Agritech Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 16.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 4,841.19 Cr, Dhanuka Agritech Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Dhanuka Agritech Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Dhanuka Agritech Ltd is 16.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
The company approved a buyback of up to 5,00,000 equity shares at ₹1,400 per share, with an aggregate offer size of ₹70 crore.
The board approved a buyback of up to ₹70 crore at ₹1,400 per share, excluding transaction costs.
The Board approved a tender offer buyback of up to 5,00,000 shares (1.11% of paid-up equity) at ₹1,400 per share, for an aggregate amount up to ₹70 crore.
The board approved a buyback of up to ₹70 crore at a buyback price of ₹1,400 per share, via the tender offer route.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
868.45 | 7,835 Cr | 11.51 | 2.50 | 1.73 | 21.71 | 27.03 | 11.78 | ||
1087.90 | 4,841 Cr | 16.30 | 3.45 | 0.19 | 21.17 | 26.61 | 16.50 | ||
227.50 | 4,413 Cr | 23.98 | 2.16 | 1.32 | 9.88 | 13.59 | 5.50 | ||
169.25 | 3,969 Cr | 868.54 | 5.81 | 0.00 | 2.49 | 7.39 | 0.34 | ||
233.15 | 3,060 Cr | 168.42 | 4.38 | 0.06 | 2.60 | 4.13 | 1.62 | ||
1370.10 | 2,294 Cr | 15.74 | 1.80 | 0.00 | 11.43 | 15.51 | 10.17 | ||
705.35 | 2,052 Cr | 14.72 | 1.68 | 0.00 | 11.42 | 14.78 | 6.97 | ||
| Median: 7 Co. | — | 705.35 | 3,969 Cr | 16.30 | 2.50 | 0.06 | 11.42 | 14.78 | 6.97 |
Share Buyback
Dhanuka Agritech published a public notice for a tender offer buyback of up to 500,000 equity shares at Rs 1,400 per share (aggregate up to Rs 70.00 crore) via stock‑exchange mechanism; notice in Business Standard and on company website.
Buyback Notice
Dhanuka Agritech published a public notice (June 8, 2026) for a tender-offer buyback of up to 500,000 equity shares at ₹1,400 each (aggregate up to ₹70.00 crore), published in Business Standard (Hindi & English).
Buyback Notice
Sundae Capital Advisors submitted to BSE a Public Notice (dated June 8, 2026) that Dhanuka Agritech Ltd will conduct an equity share buyback via tender offer under SEBI Buyback Regulations; notice published in Business Standard (English & Hindi, all editions).
Buyback Opening
On June 3, 2026, Sundae Capital Advisors (Manager) submitted the offer opening advertisement cum corrigendum for Dhanuka Agritech’s equity share buyback (tender offer) under SEBI Buyback Regulations, published in Business Standard (English & Hindi).
Buyback Notice
Dhanuka Agritech announced a buyback of up to 500,000 equity shares at ₹1,400/share (up to ₹70.00 crore); Letter of Offer, tender forms and SH‑4 were dispatched on June 2, 2026 and opening advertisement/corrigendum published June 3, 2026.
